PubMed impact filter
ElixirFeed screens PubMed research, ranks papers by likely biomedical impact, and explains the few studies worth opening first.
PubMed impact filter
PubMed is comprehensive by design, which makes it hard to use as a daily signal feed. ElixirFeed turns broad PubMed output into a sparse, ranked layer for readers who want to know which biomedical papers deserve attention first.
Scores candidates before writing summaries
Prioritizes strong human evidence and clinically meaningful endpoints
Keeps journal, author, and institution prominence capped so prestige cannot rescue weak findings
Workflow
ElixirFeed keeps the ranking workflow visible because the differentiator is the filter, not generic article rewriting.
ElixirFeed starts with the biomedical firehose rather than one narrow keyword query.
Records without usable abstracts and obvious low-impact matches are removed before enrichment.
Human evidence, clinical relevance, public usefulness, novelty, journal context, and prominence signals shape the score.
The highest-ranking studies become readable briefs with takeaways, caveats, categories, and source links.
A useful PubMed impact filter starts by throwing most papers away. ElixirFeed evaluates evidence quality, practical relevance, public importance, novelty, study type, and external credibility signals before a paper reaches the feed.
Important biomedical papers are rare. The product goal is not to mirror PubMed search results, but to identify the small set of studies that are more likely to change awareness, decisions, or follow-up reading.
Once a paper clears the impact screen, ElixirFeed explains what was found, what remains uncertain, why the paper was selected, and how strong the evidence appears.
Clinicians tracking major biomedical findings
Biotech founders watching translational signals
Health and longevity readers avoiding abstract overload
ElixirFeed is a research discovery product, not medical advice or a replacement for source-paper review.
No. PubMed remains the source index. ElixirFeed is a triage layer for discovering high-signal biomedical papers faster.
No. The product now screens broad biomedical research across human health, disease, medical innovation, fundamental science, and public health.
Candidates are filtered and scored for evidence quality, impact, relevance, novelty, study type, and capped external prominence signals.
Start with the public preview, then create a free account when you want the regular recent feed.